Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Sector: Medical
Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX)
3m
6m
1y
2y
Ranking History
This Week
Last Week
Two Weeks Back
Three Weeks Back
Please login to view our current ranking data
Click here to login
No Information
No Information
No Information
Disclaimer
Headlines
Blog Articles
Premium News
Press Releases
SEC
Æterna Zentaris Partner, Keryx Biopharmaceuticals, Announces Poster Presentation Highlighting Clinical Activity of Perifosine (KRX-0401) at 51st Annual Meeting of the American Society of Hematology
Nov 11, 2009 08:36 AM |
AEZ
,
AEZS
,
KERX
Æterna Zentaris: son partenaire Keryx Biopharmaceuticals fera une présentation sur affiche portant sur l'activité clinique de perifosine (KRX-0401) à la 51ième assemblée annuelle de l'American Society of Hematology
Nov 11, 2009 08:36 AM |
AEZ
,
AEZS
,
KERX
AEterna Zentaris Partner, Keryx Biopharmaceuticals, Announces Poster Presentation Highlighting Clinical Activity of Perifosine (KRX-0401) at 51st Annual Meeting of the American Society of Hematology
Nov 11, 2009 08:35 AM |
AEZ
,
AEZS
,
KERX
Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology
Nov 11, 2009 08:30 AM |
AEZS
,
KERX
Æterna Zentaris Reports Third Quarter 2009 Financial and Operating Results
Nov 11, 2009 07:03 AM |
AEZ
,
AEZS
,
KERX
,
MRK
Æterna Zentaris annonce ses résultats financiers et d'exploitation du troisième trimestre de 2009
Nov 11, 2009 07:02 AM |
AEZ
,
AEZS
,
KERX
,
MRK
AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results
Nov 11, 2009 07:01 AM |
AEZ
,
AEZS
,
KERX
Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results
Nov 09, 2009 04:30 PM |
KERX
Æterna Zentaris: Scientific Article Supports Perifosine's Development in Kidney Cancer
Nov 09, 2009 07:07 AM |
AEZ
,
KERX
Æterna Zentaris: un article scientifique appuie le développement de perifosine en cancer du rein
Nov 09, 2009 07:06 AM |
AEZ
,
KERX
More..
AEterna Zentaris Reports Second Quarter 2009 Financial and Operating Results
Aug 11, 2009 07:57 AM |
AEZS
,
KERX
More..
PicksThatMove.Com Announces Investment Opinion: Risk and Reward on Momentum Investing
Sep 23, 2009 11:12 AM |
CEGE
,
KERX
,
OPXA
,
QTWW
,
WAVE
PicksThatMove.Com Announces Investment Opinion: Small Cap Biopharmaceuticals and Biotechnology 101 From PicksThatMove
Sep 15, 2009 05:51 PM |
ARIA
,
DSCO
,
KERX
,
THC
BenchmarkJournal.Com Free Analyst Review for KERX, MEDX, AMCC, HBAN, JBLU and LNCR
Aug 11, 2009 10:20 AM |
AMCC
,
HBAN
,
JBLU
,
KERX
,
LNCR
,
MEDX
StockPreacher.Com Issues Trading Outlook for Keryx Biopharmaceuticals Inc.
Aug 10, 2009 07:51 AM |
AMGN
,
BAX
,
FOLD
,
GENZ
,
KERX
Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results ; Keryx to Host Investor Conference Call on Thursday, August 6, 2009 at 8:30am EDT
Aug 05, 2009 06:52 PM |
KERX
Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
Aug 05, 2009 04:55 PM |
KERX
Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday, August 6, 2009 at 8:30am EDT
Aug 04, 2009 04:30 PM |
KERX
Keryx Biopharmaceuticals Settles License Dispute With Alfa Wassermann
Aug 04, 2009 08:31 AM |
KERX
Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX-0401 (Perifosine) in the Treatment of Multiple Myeloma
Aug 03, 2009 08:32 AM |
KERX
Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
Jul 14, 2009 08:31 AM |
KERX
More..
Form 4 KERYX BIOPHARMACEUTICALS For: Nov 07 Filed by: Fowler Wyche JR (10K)
Nov 09, 2009 05:42 PM
Form 4 KERYX BIOPHARMACEUTICALS For: Sep 19 Filed by: Kaye Jack (10K)
Sep 22, 2009 06:58 PM
Form 4 BENTSUR RON For: Sep 22 (10K)
Sep 22, 2009 06:56 PM
Form 4 BENTSUR RON For: Jun 23 (10K)
Jun 24, 2009 10:03 AM
Form 4 KERYX BIOPHARMACEUTICALS For: Jun 16 Filed by: Kaye Jack (10K)
Jun 18, 2009 06:50 PM
Form 4 KERYX BIOPHARMACEUTICALS For: Jun 17 Filed by: Fowler Wyche JR (10K)
Jun 18, 2009 06:49 PM
Form 4 KERYX BIOPHARMACEUTICALS For: Jun 16 Filed by: Cameron Kevin J (10K)
Jun 18, 2009 06:45 PM
Form 4 KERYX BIOPHARMACEUTICALS For: Jun 16 Filed by: Tarnok Michael P. (10K)
Jun 18, 2009 06:44 PM
Form 4 KERYX BIOPHARMACEUTICALS For: Jun 04 Filed by: Fowler Wyche JR (10K)
Jun 04, 2009 01:22 PM
Form 4 KERYX BIOPHARMACEUTICALS For: May 26 Filed by: Tarnok Michael P. (10K)
May 27, 2009 01:43 PM
More..
Analyst Ratings
More Details
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
KERX
Compare to S&P
YTD
944.03 %
764.06 %
4 Weeks
6.98 %
5.82 %
12 Weeks
65.47 %
56.00 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-96.55 %
EPS Growth in Last Year:
106.67 %
Sales Growth in Last Quarter:
-80.94 %
Sales Growth in Last Quarter:
851.09 %
More...
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
